However, LAG-3′s role in immune evasion is carried out through its activation by corresponding ligands on tumor cells and downstream inhibitory signaling pathways that inhibit cytotoxic and cytokine production by CD8 T cells. This evidence concerns the gene CD8A and neoplasm.